Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SNX281 |
| Trade Name | |
| Synonyms | SNX-281|SNX 281 |
| Drug Descriptions |
SNX281 acts as an agonist to stimulator of interferon genes (STING, TMEM173), which activates the immune system by stimulating cells in the tumor microenvironment, potentially resulting in a cytotoxic T-lymphocyte response against tumor cells (NCI Drug dictionary). |
| DrugClasses | STING1 Agonist 21 |
| CAS Registry Number | NA |
| NCIT ID | C179271 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pembrolizumab + SNX281 | Pembrolizumab SNX281 | 0 | 1 |
| SNX281 | SNX281 | 0 | 1 |